21
Participants
Start Date
April 2, 2019
Primary Completion Date
November 7, 2024
Study Completion Date
November 7, 2024
Blood sampling
"Before the anti-CD20 monoclonal antibodies treatment (e.g. Rituximab/Ofatumumab) and after 6, 9 and 12, 24 months from the first infusion the following blood samples will be collected for the analysis of lymphocyte subpopulations:~* 50/100 mL of blood (20 mL for pediatric patients) for Peripheral Blood Mononuclear Cells (PBMCs) isolation.~* 8 mL of blood (both adult and pediatric) to obtain serum. Serum will be obtained by standard centrifugation and PBMC will be isolated by Ficoll-Paque® density gradient centrifugation, according to manufacturer's instruction."
"Centro di Ricerche Cliniche per le Malattie Rare Aldo e Cele Daccò", Ranica
Mario Negri Institute for Pharmacological Research
OTHER